BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 265 filers reported holding BIONTECH SE in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,394 | -22.2% | 31,240 | -22.7% | 0.04% | +18.2% |
Q2 2023 | $4,360 | -57.2% | 40,399 | -50.6% | 0.03% | -72.0% |
Q1 2023 | $10,191 | +238.1% | 81,812 | +307.7% | 0.12% | +218.9% |
Q4 2022 | $3,014 | -100.0% | 20,065 | -69.5% | 0.04% | -66.4% |
Q3 2022 | $8,875,000 | -35.6% | 65,799 | -28.8% | 0.11% | -25.2% |
Q2 2022 | $13,772,000 | -48.7% | 92,369 | -41.3% | 0.15% | -25.4% |
Q1 2022 | $26,824,000 | -41.0% | 157,270 | -10.9% | 0.20% | -20.2% |
Q4 2021 | $45,482,000 | +17.6% | 176,422 | +24.6% | 0.25% | +35.7% |
Q3 2021 | $38,667,000 | +12.4% | 141,641 | -7.9% | 0.18% | +13.8% |
Q2 2021 | $34,412,000 | +89.6% | 153,707 | -7.5% | 0.16% | +68.4% |
Q1 2021 | $18,148,000 | +28.9% | 166,208 | -3.8% | 0.10% | +26.7% |
Q4 2020 | $14,078,000 | +128.8% | 172,698 | +94.3% | 0.08% | +92.3% |
Q3 2020 | $6,153,000 | +158.4% | 88,877 | +149.1% | 0.04% | +95.0% |
Q2 2020 | $2,381,000 | +1133.7% | 35,681 | +978.3% | 0.02% | +900.0% |
Q1 2020 | $193,000 | – | 3,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |